Opportunity Information: Apply for CDC RFA OE15 150102CONTPPHF16
Apply for CDC RFA OE15 150102CONTPPHF16
- The HHS-CDC in the health sector is offering a public funding opportunity titled "PPHF 2016: Immunization Grants – Strengthening Public Health Laboratories - Financed in part by 2016 Prevention and Public Health Funds" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.322, 93.765.
- This funding opportunity was created on Mar 23, 2016 and posted on Mar 23, 2016.
- Applicants must submit their applications by Apr 15, 2016. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
This funding opportunity, titled "PPHF 2016: Immunization Grants - Strengthening Public Health Laboratories - Financed in part by 2016 Prevention and Public Health Funds," is a continuation cooperative agreement issued by the U.S. Department of Health and Human Services, Centers for Disease Control and Prevention (HHS-CDC). It is part of CDC's immunization-related grant portfolio and is supported in part through the Prevention and Public Health Fund (PPHF) for fiscal year 2016, which is a federal funding stream intended to bolster prevention efforts and strengthen public health infrastructure.
The opportunity is identified by Funding Opportunity Number CDC RFA OE15-150102CONTPPHF16 and is categorized under the Health funding activity area. It is listed under CFDA numbers 93.322 and 93.765, indicating it aligns with established federal assistance programs that support public health preparedness and immunization program infrastructure. The stated focus is on strengthening public health laboratories, which generally refers to improving the capacity of state, local, territorial, or other designated public health labs to support immunization programs through better testing, surveillance support, quality systems, and related laboratory functions that help prevent and control vaccine-preventable diseases.
Because this is a continuation opportunity and uses a cooperative agreement mechanism, the structure implies an ongoing program where CDC has substantial involvement beyond simply issuing funds. In cooperative agreements, recipients typically carry out the day-to-day work while CDC provides programmatic guidance, technical assistance, and collaboration on strategy, performance, and public health priorities. Continuation opportunities commonly target existing awardees or participants in an established program, rather than opening competition broadly, and they are often used to extend or renew funding for work already underway. The listing reflects this by placing eligible applicants under "Others" and directing readers to an additional eligibility section in the full announcement for the exact eligibility rules and any limitations on who may apply.
Key administrative details include an original and current closing date of April 15, 2016, indicating a fixed deadline without later extension in the posted record. The opportunity was created and posted on March 23, 2016, suggesting a relatively short application window typical of continuation or non-competitive renewals. The award ceiling is shown as 0 in the summary record, which often means the ceiling was not specified in the public synopsis, varies by recipient, is determined by formula or continuation amounts, or is otherwise detailed in the full funding announcement rather than the abstract. The expected number of awards is not listed in the provided synopsis, which can happen when awards are predetermined for existing recipients, depend on appropriations, or are described elsewhere in the full notice.
Overall, the grant opportunity is best understood as CDC providing continued financial and technical support to strengthen public health laboratory capacity in direct connection with immunization program goals, funded in part by the FY 2016 Prevention and Public Health Funds. It sits within CDC's broader effort to maintain and improve the infrastructure needed to detect, monitor, and respond to vaccine-preventable diseases, with laboratory capability serving as a critical support function for immunization and surveillance activities.
FAQs: PPHF 2016 Immunization Grants - Strengthening Public Health Laboratories
What is the title of this funding opportunity?
The opportunity is titled "PPHF 2016: Immunization Grants - Strengthening Public Health Laboratories - Financed in part by 2016 Prevention and Public Health Funds."
Which federal agency is offering this opportunity?
This is a continuation cooperative agreement issued by the U.S. Department of Health and Human Services (HHS), Centers for Disease Control and Prevention (CDC).
What is the Funding Opportunity Number (FON)?
The Funding Opportunity Number is CDC RFA OE15-150102CONTPPHF16.
What is the funding activity area for this opportunity?
The opportunity is categorized under the Health funding activity area.
What CFDA numbers are associated with this grant?
The CFDA numbers listed for this opportunity are 93.322 and 93.765.
What is the main purpose or focus of the funding?
The stated focus is strengthening public health laboratories in support of immunization program goals, including laboratory functions that help prevent and control vaccine-preventable diseases.
What does "strengthening public health laboratories" mean in this context?
Based on the synopsis, it generally refers to improving public health laboratory capacity to support immunization programs through better testing, surveillance support, quality systems, and related laboratory functions tied to vaccine-preventable disease prevention and control.
Is this part of a broader CDC program area?
Yes. The opportunity is described as part of CDC's immunization-related grant portfolio and supports infrastructure needed to detect, monitor, and respond to vaccine-preventable diseases.
What type of award mechanism is being used?
The opportunity uses a cooperative agreement mechanism.
What does a cooperative agreement imply about CDC's role?
In a cooperative agreement, recipients typically carry out day-to-day work while CDC has substantial involvement, such as providing programmatic guidance, technical assistance, and collaboration on strategy, performance, and public health priorities.
Is this a new competitive grant or a continuation?
This is described as a continuation opportunity, meaning it continues an ongoing program rather than representing a brand-new standalone competition.
Who is eligible to apply?
The synopsis lists eligible applicants under "Others" and indicates that applicants should refer to an additional eligibility section in the full announcement for exact eligibility rules and any limitations.
Does this opportunity likely target existing awardees?
Yes. The synopsis explains that continuation opportunities commonly target existing awardees or participants in an established program rather than opening competition broadly.
What is the application deadline?
The original and current closing date shown is April 15, 2016.
Was the deadline extended?
The record indicates the original and current closing date are the same (April 15, 2016), suggesting no extension in the posted synopsis.
When was the opportunity posted?
The opportunity was created and posted on March 23, 2016.
How long was the application window based on the posted and closing dates?
Based on the posted date (March 23, 2016) and the closing date (April 15, 2016), the window appears relatively short, which the synopsis notes can be typical for continuation or non-competitive renewals.
What is the award ceiling?
The award ceiling is shown as 0 in the summary record.
Does an award ceiling of 0 mean no funding is available?
Not necessarily. The synopsis indicates that a ceiling of 0 often means the ceiling was not specified in the public synopsis, varies by recipient, is determined by formula or continuation amounts, or is detailed in the full announcement rather than the abstract.
How many awards does CDC expect to make?
The expected number of awards is not listed in the provided synopsis.
Why might the number of awards not be listed?
The synopsis notes this can happen when awards are predetermined for existing recipients, depend on appropriations, or are described elsewhere in the full notice.
How is this opportunity funded?
It is financed in part by the FY 2016 Prevention and Public Health Fund (PPHF).
What is the Prevention and Public Health Fund (PPHF) as described here?
The synopsis describes PPHF as a federal funding stream intended to bolster prevention efforts and strengthen public health infrastructure.
What public health outcomes is this grant intended to support?
Based on the synopsis, the funding supports laboratory capability as a critical function for immunization and surveillance activities that help detect, monitor, and respond to vaccine-preventable diseases.
Where can applicants find the precise eligibility rules and other details not included in the synopsis?
The synopsis directs readers to the full announcement, including an additional eligibility section, for exact eligibility rules, limitations, and details not specified in the abstract.
Browse more opportunities from the same category: Health
Next opportunity: Television Drama Series to Combat Violent Extremism
Previous opportunity: Iowa Conservation Collaboration Grants Fiscal Year 2016
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for CDC RFA OE15 150102CONTPPHF16
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (CDC RFA OE15 150102CONTPPHF16) also looked into and applied for these:
| Funding Opportunity |
|---|
| Developing and Disseminating Targeted Immunization Materials Apply for CDC RFA IP16 1601 Funding Number: CDC RFA IP16 1601 Agency: HHS-CDC-NCIRD Category: Health Funding Amount: $300,000 |
| Fetal Alcohol Spectrum Disorders Practice and Implementation Centers - High-Impact Projects for Practice and Systems Change Apply for CDC RFA DD14 14020301SUPP16 Funding Number: CDC RFA DD14 14020301SUPP16 Agency: HHS-CDC-NCBDDD Category: Health Funding Amount: $151,200 |
| Partnerships to Improve Community Health (PICH) Apply for CDC RFA DP14 141703CONT16 Funding Number: CDC RFA DP14 141703CONT16 Agency: HHS-CDC Category: Health Funding Amount: Case Dependent |
| Maternal and Child Health Measurement Research Network Apply for HRSA 16 034 Funding Number: HRSA 16 034 Agency: HHS-HRSA Category: Health Funding Amount: Case Dependent |
| International AIDS Education and Training Center Apply for HRSA 16 174 Funding Number: HRSA 16 174 Agency: HHS-HRSA Category: Health Funding Amount: Case Dependent |
| Health Communication and Marketing (HCM) Kenya Apply for RFA 615 16 000002 Funding Number: RFA 615 16 000002 Agency: USAID-KEN Category: Health Funding Amount: $42,500,000 |
| Economic Modeling for HIV, Viral Hepatitis, Sexually Transmitted Diseases, Tuberculosis and School Health Apply for CDC RFA PS14 141503CONT16 Funding Number: CDC RFA PS14 141503CONT16 Agency: HHS-CDC Category: Health Funding Amount: Case Dependent |
| Discovery of the Genetic Basis of Childhood Cancers and of Structural Birth Defects: Gabriella Miller Kids First Pediatric Research Program (X01) Apply for PAR 16 150 Funding Number: PAR 16 150 Agency: HHS-NIH11 Category: Health Funding Amount: Case Dependent |
| Office of Tribal Self-Governance Planning Cooperative Agreement Apply for HHS 2016 IHS TSGP 0001 Funding Number: HHS 2016 IHS TSGP 0001 Agency: HHS-IHS Category: Health Funding Amount: $120,000 |
| Office of Tribal Self-Governance Negotiation Cooperative Agreement Apply for HHS 2016 IHS TSGN 0001 Funding Number: HHS 2016 IHS TSGN 0001 Agency: HHS-IHS Category: Health Funding Amount: $48,000 |
| Prescription Drug Overdose: Data-Driven Prevention Initiative (DDPI) Apply for CDC RFA CE16 1606 Funding Number: CDC RFA CE16 1606 Agency: HHS-CDC-NCIPC Category: Health Funding Amount: $750,000 |
| PPHF 2016: Immunization Grants - Increasing IIS Sentinel Site Capacity for Enhanced Program Support – Financed in part by 2016 Prevention and Public Health Funds Apply for CDC RFA IP14 140703CONTPPHF16 Funding Number: CDC RFA IP14 140703CONTPPHF16 Agency: HHS-CDC-NCIRD Category: Health Funding Amount: Case Dependent |
| PPHF 2016: Epidemiology and Laboratory Capacity Program – Emerging Infections Programs – Financed in part by 2016 Prevention and Public Health Funds Apply for CDC RFA CK12 120905CONTPPHF16 Funding Number: CDC RFA CK12 120905CONTPPHF16 Agency: HHS-CDC-NCEZID Category: Health Funding Amount: Case Dependent |
| Collecting Violent Death Information Using the National Violent Death Reporting System (NVDRS) Apply for CDC RFA CE16 1607 Funding Number: CDC RFA CE16 1607 Agency: HHS-CDC-NCIPC Category: Health Funding Amount: $878,000 |
| Tailoring Dental Treatment for Individuals with Systemic Diseases that Compromise Oral Health (R01) Apply for PAR 16 154 Funding Number: PAR 16 154 Agency: HHS-NIH11 Category: Health Funding Amount: Case Dependent |
| Tailoring Dental Treatment for Individuals with Systemic Diseases that Compromise Oral Health (R21) Apply for PAR 16 153 Funding Number: PAR 16 153 Agency: HHS-NIH11 Category: Health Funding Amount: $200,000 |
| NeuroNEXT Clinical Trials (U01) Apply for PAR 16 155 Funding Number: PAR 16 155 Agency: HHS-NIH11 Category: Health Funding Amount: Case Dependent |
| Newborn Screening Implementation Program Regarding Conditions Added to the Recommended Uniform Screening Panel (RUSP) Apply for HRSA 16 062 Funding Number: HRSA 16 062 Agency: HHS-HRSA Category: Health Funding Amount: Case Dependent |
| Use of Imaging and Digital Image Analysis Software/s to Evaluate Transdermal Irritation and Non - inferiority of Generic Transdermal Products (U01) Apply for RFA FD 16 010 Funding Number: RFA FD 16 010 Agency: HHS-NIH11 Category: Health Funding Amount: $250,000 |
| Generic Drug Substitution in Special Populations (U01) Apply for RFA FD 16 011 Funding Number: RFA FD 16 011 Agency: HHS-NIH11 Category: Health Funding Amount: $200,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "CDC RFA OE15 150102CONTPPHF16", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.